Purpose: There remains an unmet medical need for radioprotective and mitigative agents. BP-C2 is a novel lignin-derived polyphenolic composition with ammonium molybdate, developed as radioprotector/radiomitigator.
Objectives: The present study evaluated BP-C2 for the mitigation of acute radiation syndrome (ARS).